てんかん手術の世界市場は、レビュー期間中にCAGR 5.72%という顕著な年平均成長率を記録し、2027年末には14億232万米ドルを超えると予測されています。てんかんの手術は、発作の可能性を最小限に抑えるために行われます。 発展途上の事業部門は、機械的進歩、発作の問題に傾倒する発展途上の高齢者人口、およびてんかんの医療処置に関する研究イニシアチブに取り組む政府の推進力のために、市場で働く世界中の市場プレーヤーに潜在的な開発の機会を提供することが期待されます。てんかんの医療処置市場は、ガジェットの迅速な機械的進歩、より良い診療所、慎重な治療を必要とする患者プールの拡大などの変数に起因して、レビュー期間にわたって重要な発展を示すと予測されています。
てんかん手術の世界市場は、てんかん治療装置の研究開発につながる神経疾患の増加や、交通事故の増加による脳損傷の有病率の上昇により、健全な市場拡大が見込まれ、著しい成長率が期待されます。また、ロボットによる医療処置の進展や高齢者人口の増加が、市場の発展を促すと思われます。ただし、てんかん手術に関連する変化が市場発展を抑制する可能性があります。
手術の種類によって、世界の市場は切除手術、レーザー間質性温熱療法（LITT）、その他に分類されます。エンドユーザー別では、病院・診療所、専門センター、その他に分類されています。
南北アメリカは、接地された医療サービスオフィスへのアクセス可能性、神経学的問題の高い罹患率、てんかんの拡大率などのさまざまな要素により、てんかん医療処置市場を支配する可能性があります。北アメリカはアメリカ国とカナダに分かれています 約15万人のアメリカ人が、発作を引き起こし、4番目に多い神経感染症である中枢神経系（CNS疾患であると評価されています。
アジア太平洋地域は、てんかん医療処置市場のプレーヤーにやりがいのある自由を提供します。これは、巨大な高齢者人口の存在、医療分野をさらに発展させるための立法措置、研究開発活動の増加、この地域におけるてんかんの発生数の増加によって推進されています。中東・アフリカのてんかん医療処置市場は、中東、アフリカ、ラテンアメリカといった重要な地域に細分化されています。
本レポートは、COVID-19の大流行があらゆる領域の様々な産業や業種に与える影響を継続的に追跡しています。当社の調査レポートには、COVID-19が各産業に与える影響による低下と上昇を理解するのに役立つ情報が記載されています。また、関心のある市場の需要と供給のギャップを特定するのに役立ちます。さらに、このレポートは、分析、政府規制の修正、およびその他の多くの有用な洞察に役立ちます。
目次
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF EPILEPSY AND DEMAND FOR SURGICAL PROCEDURES
4.2.2 RISING NUMBER OF CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS
4.2.3 ADVANCEMENT AND ADOPTION OF ROBOT-ASSISTED SURGERY
4.3 RESTRAINT
4.3.1 STRINGENT GOVERNMENT REGULATIONS AND COMPLICATIONS ASSOCIATED WITH SURGERY
4.4 OPPORTUNITY
4.4.1 COLLABORATION WITH RESEARCH INSTITUTES FOR MARKET ENTRANTS TO ACCESS GLOBAL MARKETS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION
5.1.4 MARKETING & SALES
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF BUYERS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON DEMAND
5.3.3 AVAILABILITY AND ACCESS TO HEALTHCARE FACILITIES
5.3.4 IMPACT ON REVENUE AND STRATEGIC DECISIONS BY COMPANIES
6 GLOBAL EPILEPSY SURGERY MARKET BY PROCEDURE TYPE
6.1 OVERVIEW
6.2 RESECTIVE SURGERY
6.3 LASER INTERSTITIAL THERMAL THERAPY (LITT)
6.4 OTHERS
7 GLOBAL EPILEPSY SURGERY MARKET BY END USER
7.1 OVERVIEW
7.2 HOSPITALS & CLINICS
7.3 SPECIALTY CENTERS
7.4 OTHERS
8 GLOBAL EPILEPSY SURGERY MARKET, BY REGION
8.1 OVERVIEW
8.2 AMERICAS
8.2.1 NORTH AMERICA
8.2.1.1 US
8.2.1.2 CANADA
8.2.2 LATIN AMERICA
8.3 EUROPE
8.3.1 WESTERN EUROPE
8.3.1.1 GERMANY
8.3.1.2 UK
8.3.1.3 FRANCE
8.3.1.4 ITALY
8.3.1.5 SPAIN
8.3.1.6 REST OF WESTERN EUROPE
8.3.2 EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 CHINA
8.4.2 JAPAN
8.4.3 INDIA
8.4.4 SOUTH KOREA
8.4.5 AUSTRALIA
8.4.6 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST
8.5.2 AFRICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY SURGERY MARKET
9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY SURGERY MARKET
9.5 KEY DEVELOPMENT ANALYSIS
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
9.6.2 MERGER/ACQUISITION
9.7 FINANCIAL MATRIX
9.7.1 SALES (USD MILLION), 2020
9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020
10 COMPANY PROFILES
10.1 STRYKER
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS/SERVICES OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 ZIMMER BIOMET HOLDINGS INC.
10.2.1 COMPANY OVERVIEWS
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS/SERVICES OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.)
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS/SERVICES OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 KEY STRATEGIES
10.4 INTUITIVE SURGICAL
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS/SERVICES OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGIES
10.5 MEDTRONIC PLC (MAZOR ROBOTICS)
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS/SERVICES OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6.4 KEY DEVELOPMENTS
10.7 CMR SURGICAL
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS/SERVICES OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 KEY STRATEGIES
10.8 NATUS MEDICAL INCORPORATED
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 LIVANOVA PLC
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 KEY STRATEGIES
10.10 MONTERIS MEDICAL
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS/SERVICES OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 SWOT ANALYSIS
10.10.6 KEY STRATEGIES
11 APPENDIX
11.1 REFERENCES
11.2 RELATED REPORTS
?
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 4 GLOBAL: EPILEPSY SURGERY MARKET, BY RESECTIVE SURGERY, 2018-2027 (USD MILLION)
TABLE 5 GLOBAL: EPILEPSY SURGERY MARKET, BY LASER INTERSTITIAL THERMAL THERAPY (LITT), 2018-2027 (USD MILLION)
TABLE 6 GLOBAL: EPILEPSY SURGERY MARKET, BY OTHERS, 2018-2027 (USD MILLION)
TABLE 7 GLOBAL: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 8 GLOBAL: EPILEPSY SURGERY MARKET, BY HOSPITALS & CLINICS, 2018-2027 (USD MILLION)
TABLE 9 GLOBAL: EPILEPSY SURGERY MARKET, BY SPECIALTY CENTERS, 2018-2027 (USD MILLION)
TABLE 10 GLOBAL: EPILEPSY SURGERY MARKET, BY OTHERS, 2018-2027 (USD MILLION)
TABLE 11 GLOBAL: EPILEPSY SURGERY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 12 AMERICAS EPILEPSY SURGERY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 AMERICAS EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 14 AMERICAS EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 15 NORTH AMERICA EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 16 NORTH AMERICA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 17 NORTH AMERICA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 18 US EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 19 US EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 20 CANADA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 21 CANADA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 22 LATIN AMERICA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 23 LATIN AMERICA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 24 EUROPE EPILEPSY SURGERY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 26 EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 27 WESTERN EUROPE EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 28 WESTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 29 AMERICAS EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 30 GERMANY EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 31 GERMANY EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 32 UK EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 33 UK EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 34 FRANCE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 35 FRANCE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 36 ITALY EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 37 ITALY EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 38 SPAIN EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 39 SPAIN EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 40 REST OF WESTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 41 REST OF WESTERN EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 42 EASTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 43 EASTERN EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 44 ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 45 ASIA-PACIFIC: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 46 ASIA-PACIFIC: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 47 CHINA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 48 CHINA: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 49 JAPAN: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 50 JAPAN: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 51 INDIA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 52 INDIA: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 53 SOUTH KOREA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 54 SOUTH KOREA: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 55 AUSTRALIA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 56 AUSTRALIA: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 57 REST OF ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 58 REST OF ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 62 MIDDLE EAST: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 63 MIDDLE EAST: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 64 AFRICA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 65 AFRICA: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 66 MAJOR PLAYERS IN THE GLOBAL EPILEPSY SURGERY MARKET
TABLE 67 MOST ACTIVE PLAYER IN THE GLOBAL EPILEPSY SURGERY MARKET
TABLE 68 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 69 MERGER/ACQUISITION
TABLE 70 STRYKER: PRODUCTS/SERVICES OFFERED
TABLE 71 ZIMMER BIOMET HOLDINGS INC.: PRODUCTS/SERVICES OFFERED
TABLE 72 ZIMMER BIOMET HOLDINGS INC: KEY DEVELOPMENTS
TABLE 73 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): PRODUCTS/SERVICES OFFERED
TABLE 74 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): KEY DEVELOPMENTS
TABLE 75 INTUITIVE SURGICAL: PRODUCTS/SERVICES OFFERED
TABLE 76 INTUITIVE SURGICAL: KEY DEVELOPMENTS
TABLE 77 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED
TABLE 78 MEDTRONIC PLC: KEY DEVELOPMENTS
TABLE 79 CEPHALON, INC.: PRODUCTS/SERVICES OFFERED
TABLE 80 CMR SURGICAL: PRODUCTS/SERVICES OFFERED
TABLE 81 CMR SURGICAL: KEY DEVELOPMENTS
TABLE 82 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED
TABLE 83 LIVANOVA PLC: PRODUCTS OFFERED
TABLE 84 MONTERIS MEDICAL: PRODUCTS/SERVICES OFFERED
TABLE 85 MONTERIS MEDICAL: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET STRUCTURE: GLOBAL EPILEPSY SURGERY MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL EPILEPSY SURGERY MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINT: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN: GLOBAL EPILEPSY SURGERY MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL EPILEPSY SURGERY MARKET
FIGURE 9 GLOBAL EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2020 & 2027 (USD MILLION)
FIGURE 10 GLOBAL EPILEPSY SURGERY MARKET, BY END USER, 2020 & 2027 (USD MILLION)
FIGURE 11 GLOBAL: EPILEPSY SURGERY MARKET, BY REGION 2020 & 2027 (USD MILLION)
FIGURE 12 GLOBAL: EPILEPSY SURGERY MARKET SHARE (%), BY REGION, 2020
FIGURE 13 AMERICAS: EPILEPSY SURGERY MARKET SHARE (%), BY REGION, 2020
FIGURE 14 NORTH AMERICA: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 15 EUROPE: EPILEPSY SURGERY MARKET SHARE (%), BY REGION, 2020
FIGURE 16 WESTERN EUROPE: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 17 ASIA PACIFIC: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 18 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL EPILEPSY SURGERY MARKET
FIGURE 21 GLOBAL EPILEPSY SURGERY MARKET: COMPETITIVE LANDSCAPE
FIGURE 22 SALES (USD MILLION), 2020
FIGURE 23 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020
FIGURE 24 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 STRYKER: SWOT ANALYSIS
FIGURE 26 ZIMMER BIOMET HOLDINGS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ZIMMER BIOMET HOLDINGS INC.: SWOT ANALYSIS
FIGURE 28 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): SWOT ANALYSIS
FIGURE 29 INTUITIVE SURGICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 INTUITIVE SURGICAL: SWOT ANALYSIS
FIGURE 31 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 34 CMR SURGICAL: SWOT ANALYSIS
FIGURE 35 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS
FIGURE 37 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 LIVANOVA PLC: SWOT ANALYSIS
FIGURE 39 MONTERIS MEDICAL SWOT ANALYSIS
